| 1 |
Kinase-Selective Enrichment Enables Quantitative Phosphoproteomics of the Kinome across the Cell Cycle
Henrik Daub, Jesper Velgaard Olsen, Michaela Bairlein et al. · Molecular Cell
Open access |
Aug 2008 |
612 |
| 2 |
Large-scale Proteomics Analysis of the Human Kinome
Felix S. Oppermann, Florian Gnad, Jesper Velgaard Olsen et al. · Molecular & Cellular Proteomics
Open access |
15 Apr 2009 |
294 |
| 3 |
Cellular Targets of Gefitinib
Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research
Open access |
15 Jan 2005 |
242 |
| 4 |
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Yi-xiang Zhang, Peter G. Knyazev, Yu. V. Cheburkin et al. · Cancer Research
|
13 Mar 2008 |
211 |
| 5 |
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Ana Herrero et al. · Cancer Cell
Open access |
Aug 2015 |
154 |
| 6 |
Proteomics strategy for quantitative protein interaction profiling in cell extracts
Kirti Sharma, Christoph K. Weber, Michaela Bairlein et al. · Nature Methods
|
13 Sep 2009 |
149 |
| 7 |
Characterization of a Conserved Structural Determinant Controlling Protein Kinase Sensitivity to Selective Inhibitors
Stephanie Blencke, Birgit Zech, Ola Engkvist et al. · Chemistry & Biology
Open access |
May 2004 |
143 |
| 8 |
NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling
Scott A. Barman et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
20 Jun 2014 |
119 |
| 9 |
Proteomics Analysis of Protein Kinases by Target Class-selective Prefractionation and Tandem Mass Spectrometry
Josef B. Wissing, Lothar Jänsch, Manfred Nimtz et al. · Molecular & Cellular Proteomics
Open access |
27 Dec 2006 |
112 |
| 10 |
Leads for antitubercular compounds from kinase inhibitor library screens
Sophie Magnet, Ruben Christiaan Hartkoorn, Rita Székely et al. · Tuberculosis
Open access |
13 Oct 2010 |
105 |
| 11 |
Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
Jan Rybniker, Jeffrey M. Chen, Claudia Corina Sala et al. · Cell Host & Microbe
Open access |
Oct 2014 |
102 |
| 12 |
The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
Vinayak Singh et al. · ACS Infectious Diseases
Open access |
30 Aug 2016 |
101 |
| 13 |
Metformin Attenuates Palmitate-Induced Endoplasmic Reticulum Stress, Serine Phosphorylation of IRS-1 and Apoptosis in Rat Insulinoma Cells
Laura Simon‐Szabó, Márton Kokas, József Mandl et al. · PLoS ONE
Open access |
4 Jun 2014 |
94 |
| 14 |
TP53 mutation‐correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53‐mutated breast cancers
Balázs Győrffy, Giulia Bottai, Jacqueline Lehmann‐Che et al. · Molecular Oncology
Open access |
5 Jan 2014 |
89 |
| 15 |
Complex regulation of autophagy in cancer – Integrated approaches to discover the networks that hold a double-edged sword
János Kubisch, Dénes Türei, László Földvári-Nagy et al. · Seminars in Cancer Biology
|
28 Jun 2013 |
87 |
| 16 |
Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
Gabor G. Nemeth, Zoltán Greff, Anna Sipos et al. · Journal of Medicinal Chemistry
Open access |
17 Apr 2014 |
81 |
| 17 |
A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling
Rita Székely, Frigyes Wáczek, István Szabadkai et al. · Immunology Letters
Open access |
7 Feb 2008 |
77 |
| 18 |
Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance
Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy et al. · Biochemical Pharmacology
|
21 Apr 2012 |
76 |
| 19 |
Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway
Carolina Lavoz, Matilde Alique, Raquel Rodrigues‐Díez et al. · The Journal of Pathology
|
24 Mar 2015 |
71 |
| 20 |
Connective tissue growth factor is a new ligand of epidermal growth factor receptor
Sandra Rayego‐Mateos, Raquel Rodrigues‐Díez, José Luis Morgado‐Pascual et al. · Journal of Molecular Cell Biology
Open access |
8 Aug 2013 |
66 |
| 21 |
Integrating molecular diagnostics into anticancer drug discovery
István Peták, Richard E. Schwab, László Őrfi et al. · Nature Reviews Drug Discovery
Review |
7 Jun 2010 |
61 |
| 22 |
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
Johannes Brägelmann et al. · Cell Reports
Open access |
Sep 2017 |
56 |
| 23 |
Small-Molecule Inhibitors of NADPH Oxidase 4
Gábor Borbély, István Szabadkai, Zoltán Horváth et al. · Journal of Medicinal Chemistry
Open access |
23 Aug 2010 |
55 |
| 24 |
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation
Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Ana Belen Sanz et al. · The Journal of Pathology
|
26 Aug 2013 |
53 |
| 25 |
How Förster Resonance Energy Transfer Imaging Improves the Understanding of Protein Interaction Networks in Cancer Biology
Gilbert O. Fruhwirth, Luis P. Fernandes, Gregory E. Weitsman et al. · ChemPhysChem
|
15 Feb 2011 |
52 |
| 26 |
Signal Transduction Therapy with Rationally Designed Kinase Inhibitors
Gÿorgý Kéri, László Őrfi, Dániel Erös et al. · Current Signal Transduction Therapy
|
2006 |
49 |
| 27 |
The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients
Muireann Kelleher, Gilbert O. Fruhwirth, Gargi Surendra Patel et al. · Targeted Oncology
Open access |
Sep 2009 |
49 |
| 28 |
Katalysierte Dehalogenierungen mit Natriumborhydrid
Robert A. Egli · Helvetica Chimica Acta
|
31 Oct 1968 |
46 |
| 29 |
Design and synthesis of new imidazo[1,2- a ]pyridine and imidazo[1,2- a ]pyrazine derivatives with antiproliferative activity against melanoma cells
Rita Garamvölgyi, Judit Dobos, Anna Sipos et al. · European Journal of Medicinal Chemistry
Open access |
17 Dec 2015 |
41 |
| 30 |
Comparison of Predictive Ability of Water Solubility QSPR Models Generated by MLR, PLS and ANN Methods
Dániel Erös, Gÿorgý Kéri, István Kövesdi et al. · Mini-Reviews in Medicinal Chemistry
|
Feb 2004 |
41 |
| 31 |
Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
Robert Torka, Kinga Pénzes, Simone Gusenbauer et al. · Neoplasia
Open access |
Apr 2014 |
40 |
| 32 |
Improved, High Yield Synthesis of 3H-Quinazolin-4-ones, the Key Intermediates of Recently Developed Drugs
László Őrfi, Frigyes Wáczek, János Pató et al. · Current Medicinal Chemistry
|
Oct 2004 |
39 |
| 33 |
Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells
Robbert J. Kok, Dolman, Harmsen et al. · International Journal of Nanomedicine
Open access |
2012 |
39 |
| 34 |
The C-Terminal Module IV of Connective Tissue Growth Factor, Through EGFR/Nox1 Signaling, Activates the NF-κB Pathway and Proinflammatory Factors in Vascular Smooth Muscle Cells
Raúl R. Rodrigues-Díez, Ana B. García‐Redondo, Macarena Orejudo et al. · Antioxidants and Redox Signaling
Open access |
27 Jul 2014 |
38 |
| 35 |
An Integrated Phosphoproteomics Work Flow Reveals Extensive Network Regulation in Early Lysophosphatidic Acid Signaling
Thiemo B. Schreiber, Nina Mäusbacher, Gÿorgý Kéri et al. · Molecular & Cellular Proteomics
Open access |
13 Jan 2010 |
38 |
| 36 |
Quantitative Analysis of Kinase-Proximal Signaling in Lipopolysaccharide-Induced Innate Immune Response
Kirti Sharma, Chanchal Kumar, Gÿorgý Kéri et al. · Journal of Proteome Research
|
12 Mar 2010 |
38 |
| 37 |
Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma
Zsófia Czudor, Mária Balogh, Péter Bánhegyi et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
2 Jan 2018 |
37 |
| 38 |
The Inflammatory Kinase MAP4K4 Promotes Reactivation of Kaposi's Sarcoma Herpesvirus and Enhances the Invasiveness of Infected Endothelial Cells
Darya A. Haas, Kiran Bala, Guntram Büsche et al. · PLoS Pathogens
Open access |
7 Nov 2013 |
37 |
| 39 |
Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis
Bálint Hegymegi-Barakonyi et al. · Current Medicinal Chemistry
|
30 Oct 2008 |
36 |
| 40 |
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
István Kenessey, Tália Magdolna Keszthelyi, Zachary B. Kramer et al. · Current Cancer Drug Targets
|
27 Apr 2010 |
35 |
| 41 |
Regulation of influenza A virus mRNA splicing by CLK1
Anita Artarini et al. · Antiviral Research
Open access |
6 Jun 2019 |
34 |
| 42 |
Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model
István Kenessey, Zsófia Kramer, Lilla István et al. · Melanoma Research
|
20 Aug 2018 |
34 |
| 43 |
Identification of aminopyrimidine‐sulfonamides as potent modulators of Wag31‐mediated cell elongation in mycobacteria
Vinayak Singh et al. · Molecular Microbiology
Open access |
28 Sep 2016 |
33 |
| 44 |
Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection
Gabor G. Nemeth, Zoltán Varga, Zoltán Greff et al. · Current Medicinal Chemistry
|
2011 |
33 |
| 45 |
Drug Discovery in the Kinase Inhibitory Field Using the Nested Chemical Library™ Technology
Gÿorgý Kéri et al. · Assay and Drug Development Technologies
|
Oct 2005 |
33 |
| 46 |
Imatinib-ULS-lysozyme: A proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases
M. Emmy M. Dolman, Kim M. A. van Dorenmalen, E. Pieters et al. · Journal of Controlled Release
|
6 Sep 2011 |
33 |
| 47 |
Lead selection and characterization of antitubercular compounds using the Nested Chemical Library
Anna Sipos, János Pató, Rita Székely et al. · Tuberculosis
Open access |
28 Feb 2015 |
31 |
| 48 |
Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives
Zsolt Székelyhidi, János Pató, Frigyes Wáczek et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
Jun 2005 |
30 |
| 49 |
Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro
Csenge Szász, Domonkos Pap, Beáta Szebeni et al. · International Journal of Molecular Sciences
Open access |
13 Dec 2023 |
29 |
| 50 |
Targeted drug combination therapy design based on driver genes
Lilian Zsákai, Anna Sipos, Judit Dobos et al. · Oncotarget
Open access |
3 Sep 2019 |
29 |